Chemclin Diagnostics Co., Ltd. (688468.SS)
CNY 7.26
(0.55%)
CNY 7.26
(0.55%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 234.6 Million CNY | 1782.12% |
| 2022 | 12.46 Million CNY | -49.34% |
| 2021 | 24.6 Million CNY | 141.23% |
| 2020 | 10.19 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 220.36 Million CNY | -3.02% |
| 2024 Q2 | 252.52 Million CNY | 2.0% |
| 2024 Q1 | 247.56 Million CNY | 5.52% |
| 2023 FY | 234.6 Million CNY | 1782.12% |
| 2023 Q2 | 88.57 Million CNY | 351.06% |
| 2023 Q1 | 19.63 Million CNY | 57.54% |
| 2023 Q4 | 234.6 Million CNY | 43.12% |
| 2023 Q3 | 163.92 Million CNY | 85.06% |
| 2022 Q3 | 13.1 Million CNY | -29.45% |
| 2022 Q2 | 18.57 Million CNY | -15.89% |
| 2022 Q1 | 22.08 Million CNY | -10.25% |
| 2022 FY | 12.46 Million CNY | -49.34% |
| 2022 Q4 | 12.46 Million CNY | -4.88% |
| 2021 FY | 24.6 Million CNY | 141.23% |
| 2021 Q1 | 29.29 Million CNY | 187.25% |
| 2021 Q4 | 24.6 Million CNY | -10.1% |
| 2021 Q3 | 27.36 Million CNY | 2.16% |
| 2021 Q2 | 26.78 Million CNY | -8.57% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q4 | 10.19 Million CNY | 0.0% |
| 2020 FY | 10.19 Million CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Shanghai Runda Medical Technology Co., Ltd. | 6.85 Billion CNY | 96.575% |
| Joinn Laboratories(China)Co.,Ltd. | 85.79 Million CNY | -173.456% |
| WuXi AppTec Co., Ltd. | 5.75 Billion CNY | 95.924% |
| Autobio Diagnostics Co., Ltd. | 1.03 Billion CNY | 77.402% |
| Thalys Medical Technology Group Inc. | 1.05 Billion CNY | 77.681% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd. | 578.98 Million CNY | 59.479% |